".....but that ATL1102 modulates LTBP4 and Thrombospondin-1"
@waynesworld
Awesome to read terminology from the famous "proteomics" announcement...this ann might go down in ANP history as the company maker.
For new investors to the ANP story - i would highly recommend reading and re-reading the Proteomics ann which further explains the mechanisms of action of ATL1102.
Up until now it's been all about the Dystrophy indications: DMD, LGMD, Becker etc...but if we can pivot to something like "myocarditis" or other inflammatory settings like Asthma...
...then we await Godzilla to arrive on the scene, not a mere Gorilla in the mist
.
".....but that ATL1102 modulates LTBP4 and Thrombospondin-1"...
-
- There are more pages in this discussion • 584 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $80.23M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 9.0¢ | 8.6¢ | $2.082M | 23.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 250808 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 312804 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |